Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Transcription Factor-Mediated Reprogramming of Cancer-Associated Fibroblasts Reveals Targetable Vulnerabilities in Solid Tumors.
Journal: bioRxiv : the preprint server for biology
Published: May 04, 2026
Feasibility of the Golf Recreational Exercise for Enhanced Survivorship in prostate cancer survivors undergoing hormone therapy.
Journal: Frontiers in oncology
Published: April 01, 2026
A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: October 07, 2020
Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 17, 2020
Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer.
Journal: Prostate cancer and prostatic diseases
Published: October 04, 2019
Expression of the luteinizing hormone receptor (LHR) in ovarian cancer.
Journal: BMC cancer
Published: March 29, 2019
Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy.
Journal: Cancer
Published: December 25, 2018
Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC).
Journal: Clinical genitourinary cancer
Published: December 12, 2018
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 18, 2018
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types.
Journal: Biochemical and biophysical research communications
Published: April 05, 2018
A Phase II Trial of AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: April 03, 2017
Last Updated: 09/26/2026